Clinical Trial Update: A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating trevogrumab with or without garetosmab in combination with semaglutide for obesity; currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Garetosmab (Garetosmab)
• semaglutide (semaglutide)
• trevogrumab (trevogrumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING